Teehan Brendan
SEC insider (Form 3/4/5 filer). CIK 0001891900. Chief Commercial Officer at Pacira BioSciences, Inc. (PCRX) and 1 other issuer. 8 reported Form 4/5 transactions since Sep 2024; latest on Feb 11, 2026. Located in BRISBANE, CA.
Companies Teehan Brendan has filed insider reports for
- Pacira BioSciences, Inc. (PCRX): Officer, Chief Commercial Officer
- ACADIA PHARMACEUTICALS INC (ACAD): Officer, EVP, COO, HEAD OF COMMERCIAL
Teehan Brendan
CIK: 0001891900
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Feb 11, 2026PCRX
Pacira BioSciences, Inc.
AwardDirect51.7K shares- - Jan 30, 2026PCRX
Pacira BioSciences, Inc.
Tax PaymentDirect5.2K shares at avg. $20.54$106K - Dec 31, 2025PCRX
Pacira BioSciences, Inc.
AwardDirect402 shares at avg. $10.76$4K - Feb 4, 2025PCRX
Pacira BioSciences, Inc.
AwardDirectStock Option (Right to Buy)
99.5K shares at avg. $26.59- - Feb 1, 2025PCRX
Pacira BioSciences, Inc.
AwardDirect54K shares- - Nov 19, 2024ACAD
ACADIA PHARMACEUTICALS INC
SaleDirect10.3K shares at avg. $16.81$174K - Nov 17, 2024ACAD
ACADIA PHARMACEUTICALS INC
ExerciseDirect9.9K shares- - Nov 17, 2024ACAD
ACADIA PHARMACEUTICALS INC
ExerciseDirect9.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 11, 2026 |  PCRX Pacira BioSciences, Inc. | Award | 51,714 | - | $0 | Direct |
| Jan 30, 2026 | PCRX Pacira BioSciences, Inc. | Tax Payment | 5,182 | $20.54 | $106,438 | Direct |
| Dec 31, 2025 | PCRX Pacira BioSciences, Inc. | Award | 402 | $10.76 | $4,330 | Direct |
| Feb 4, 2025 | PCRX Pacira BioSciences, Inc. | Award Stock Option (Right to Buy) | 99,500 | $26.59 | - | Direct |
| Feb 1, 2025 | PCRX Pacira BioSciences, Inc. | Award | 54,000 | - | - | Direct |
| Nov 19, 2024 |  ACAD ACADIA PHARMACEUTICALS INC | Sale | 10,329 | $16.81 | $173,630 | Direct |
| Nov 17, 2024 | ACAD ACADIA PHARMACEUTICALS INC | Exercise | 9,913 | - | $0 | Direct |
| Nov 17, 2024 | ACAD ACADIA PHARMACEUTICALS INC | Exercise | 9,913 | - | $0 | Direct |
1-8 of 8 transactions